Study of Sorafenib With or Without VT-122 in Patients With Hepatocellular Carcinoma (HCC)
Clinical trial NCT01265576 · UNKNOWN
Trial details
- NCT number
- NCT01265576
- Sponsor
- Vicus Therapeutics
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-01
- Primary completion
- 2014-02-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.